We recently published Top 10 Trending Stocks to Watch Ahead of Nvidia Earnings. Gilead Sciences Inc (NASDAQ:GILD) is one of ...

While Gilead Sciences posted a strong Q2 earnings print, GILD stock saw profit-taking. Here's why the red ink could be an ...

Gilead Sciences (GILD) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts that could shape the stock's performance in the near term ...

Gilead Sciences (GILD) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to ...

Gilead Sciences, Inc. (GILD) Is a Trending Stock: Facts to Know Before Betting on It September 19, 2024 — 09:00 am EDT Written by Zacks Equity Research for Zacks -> ...

Gilead Sciences’ twice-yearly injectable HIV-1 capsid inhibitor, Yeytuo receives European marketing authorization: Foster City, California Thursday, August 28, 2025, 12:00 Hrs [ ...

SEC CIK GILEAD SCIENCES, INC.'s CIK is 0000882095 Past Insider Trading and Trends 2024 was GILEAD SCIENCES, INC.'s most active year for acquiring shares with 7 total transactions.

Gilead Sciences, Inc. has received the European Commission (EC) marketing authorization for Yeytuo (lenacapavir)-the ...

News about Gilead Sciences Inc. Commentary and archival information about Gilead Sciences Inc from The New York Times.

Gilead is expected to post earnings of $1.60 per share for the current quarter, representing a year-over-year change of +19.4%. Over the last 30 days, the Zacks Consensus Estimate has changed -3.2%.

News about Gilead Sciences Inc. Commentary and archival information about Gilead Sciences Inc from The New York Times.